Sanofi Respiratory Deal History & Licensing Activity
Sanofi Respiratory is a large pharma headquartered in France. Over the past three years, Sanofi Respiratory has been involved in 2 licensing and acquisition transactions, with a primary focus on Other (4 deals).
Deals (12mo)
4
Active Trials
20
Top Modality
Other
Focus Area
Ophthalmology
Sanofi Respiratory Recent Deal Activity
Licensing, acquisition, and partnership transactions involving Sanofi Respiratory in the past 12 months.
| Asset | Partner | Modality | Phase | Type | Date |
|---|---|---|---|---|---|
| AXPAXLI | Sanofi | Other | Phase 3 | acquisition | Apr 2026 |
| AXPAXLI | Sanofi | Other | Phase 3 | acquisition | Mar 2026 |
Sanofi Respiratory Pipeline Focus
Therapeutic areas and modalities where Sanofi Respiratory is most active based on deal history and clinical trial data.
Therapeutic Areas
Modalities
Sanofi Respiratory Strategic Signals
Key indicators of Sanofi Respiratory's licensing and acquisition strategy, including patent expirations, pipeline gaps, and strategic priorities.
Patent Cliffs
- Undisclosed—
Strategic Profile
Acquisition Appetite
Strategic Priorities
See How Your Asset Matches Sanofi Respiratory's Portfolio
Use our deal calculator to benchmark upfront payments, milestones, and royalties for Ophthalmology assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
Ophthalmology Deal Benchmarks
Market sizing, deal terms, and competitive landscape for ophthalmology
Other Benchmarks
Upfront, milestone, and royalty benchmarks for other deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
Browse 850+ biotech and pharma company profiles with deal history and pipeline data
2026 Deal Benchmarks Report
Industry-wide analysis of deal terms, trends, and market dynamics
About Sanofi Respiratory Licensing & Deal Activity
Sanofi Respiratory is a large pharma company based in France that has been actively engaged in licensing transactions across the biopharma landscape. With 2 deals over the past three years, Sanofi Respiratory ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for Sanofi Respiratory include Ophthalmology (4 deals and trials). In terms of modality, Sanofi Respiratory has shown particular interest in other.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Sanofi Respiratory and 850+ other biopharma companies. Use our deal calculator to benchmark your asset against Sanofi Respiratory's historical deal terms, or explore all company profiles to find the best partner match for your pipeline.